Ipamorelin
Growth Hormone Secretagogue for Recovery, Sleep, and Muscle Research
Overview
Ipamorelin is a selective growth hormone secretagogue that stimulates the release of growth hormone without significantly affecting other hormones. It is widely researched for its potential to support recovery, improve sleep quality, and enhance muscle development.
Key Benefits
Research suggests several significant primary advantages:
Supports natural growth hormone release
Encourages the body to optimize its inherent production of essential growth signaling factors.
May improve recovery and muscle repair
Potential to accelerate the restoration of physical tissue following strenuous activity or strain.
Enhances sleep quality
May lead to more restful cycles and improved overnight physical recovery.
Supports lean muscle development
Assists in the maintenance and growth of healthy, strong muscle fibers.
May aid in fat metabolism
Explored for its ability to influence metabolic processes and energy utilization throughout the body.
Mechanism of Action
Ipamorelin works by mimicking ghrelin and binding to growth hormone secretagogue receptors in the pituitary gland. This stimulates the release of growth hormone in a controlled and targeted manner without significantly increasing cortisol or prolactin levels.
Common Research Applications
Muscle growth and recovery; Sleep quality improvement; Fat loss and body composition; Growth hormone optimization.
Dosing Protocol (Research Context)
In research settings, Ipamorelin is typically administered multiple times per day to mimic natural growth hormone pulses. Typical protocols include: 200 mcg to 300 mcg per dose; Administered 1 to 3 times daily. Administration is typically performed via subcutaneous injection.
Cycle Duration
Research use is commonly conducted over periods of 8 to 12 weeks depending on study goals.
Reconstitution Guidelines
Common vial sizes include 2mg or 5mg; Typically mixed with bacteriostatic water; Store refrigerated after reconstitution.
Half-Life
Ipamorelin has a relatively short half-life, requiring multiple daily administrations for sustained effects.
Stacking Options
CJC-1295 – extended growth hormone release; Tesamorelin – additional GH support; BPC-157 – recovery and tissue repair.
Potential Side Effects
Generally well tolerated in research settings; Possible injection site irritation; Rare reports of dizziness or headache.
This compound is not approved by the FDA for human use. It is intended for research purposes only.